Antitumor Activity of Simvastatin in Preclinical Models of Mantle Cell Lymphoma

SIMPLE SUMMARY: Mantle cell lymphoma (MCL) is an aggressive subtype of B-cell non-Hodgkin lymphoma that remains incurable with standard therapy. A promising approach to overcome the low life expectancy of patients with MCL is drug repurposing, a strategy focused on finding novel therapeutic weapons...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Juliana Carvalho, Profitós-Pelejà, Núria, Ribeiro, Marcelo Lima, Roué, Gaël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688202/
https://www.ncbi.nlm.nih.gov/pubmed/36428695
http://dx.doi.org/10.3390/cancers14225601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688202/
https://www.ncbi.nlm.nih.gov/pubmed/36428695
http://dx.doi.org/10.3390/cancers14225601

Ejemplares similares